Literature DB >> 11803178

P-glycoprotein expression in mouse brain increases with maturation.

Catherine E Tsai1, Monica J Daood, Robert H Lane, Thor W R Hansen, Elisa M Gruetzmacher, Jon F Watchko.   

Abstract

The mdr1a isoform of P-glycoprotein (Pgp) is an integral plasma membrane efflux pump expressed in adult brain capillary endothelial cells and astrocytes of the blood-brain barrier. We determined the developmental pattern of Pgp expression in brain tissue at embryonic day 16 (E16), day of life 0 (D0), day of life 7 (D7), day of life 21 (D21), and adults (Ad). The relative expression of Pgp mRNA and protein was indexed as a percent (mean +/- SEM) of D0 levels. Pgp mRNA levels increased significantly (p < 0.01) with maturation (E16: 75 +/- 8%; D21: 303 +/- 37%, and Ad: 1,160 +/- 120%). Similarly, Pgp protein expression was observed at E16 and increased significantly (p < 0.01) during development (E16: 52 +/- 8%; D7: 187 +/- 23%; D21: 440 +/- 48%, and Ad: 441 +/- 56%). This developmental pattern of enhanced blood-brain barrier Pgp expression with maturation was confirmed by immunohistochemistry. We conclude that (i) Pgp expression in mouse brain is limited during late embryogenesis and the newborn period; (ii) Pgp expression increases markedly with postnatal maturation, and (iii) by D21 brain Pgp protein expression approximates adult levels. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11803178     DOI: 10.1159/000047185

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  18 in total

1.  P-glycoprotein in the developing human blood-brain barrier.

Authors:  Jon F Watchko
Journal:  Pediatr Res       Date:  2016-01-12       Impact factor: 3.756

Review 2.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 3.  Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.

Authors:  Valentina M Merola; Paul A Eubig
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-03       Impact factor: 2.093

4.  Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.

Authors:  Jean-Marie Nicolas; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2019-05-28       Impact factor: 4.009

Review 5.  Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.

Authors:  Sagar Agarwal; Anika M S Hartz; William F Elmquist; Björn Bauer
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  The ontogeny of P-glycoprotein in the developing human blood-brain barrier: implication for opioid toxicity in neonates.

Authors:  Jessica Lam; Stephanie Baello; Majid Iqbal; Lauren E Kelly; Patrick T Shannon; David Chitayat; Stephen G Matthews; Gideon Koren
Journal:  Pediatr Res       Date:  2015-06-18       Impact factor: 3.756

7.  Pharmacokinetics and dynamics of mycophenolate mofetil after single-dose oral administration in juvenile dachshunds.

Authors:  M Grobman; D M Boothe; H Rindt; B G Williamson; M L Katz; J R Coates; C R Reinero
Journal:  J Vet Pharmacol Ther       Date:  2017-06-25       Impact factor: 1.786

8.  Moxidectin toxicity in senescence-accelerated prone and resistant mice.

Authors:  Vanessa K Lee; Asheesh K Tiwary; Prachi Sharma-Reddy; Karen A Lieber; Douglas K Taylor; Deborah M Mook
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

9.  ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.

Authors:  M Daood; C Tsai; M Ahdab-Barmada; J F Watchko
Journal:  Neuropediatrics       Date:  2009-01-22       Impact factor: 1.947

10.  Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat.

Authors:  Silvia Gazzin; Andrea Lorena Berengeno; Nathalie Strazielle; Francesco Fazzari; Alan Raseni; J Donald Ostrow; Richard Wennberg; Jean-François Ghersi-Egea; Claudio Tiribelli
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.